CCL3 and malaria: The meta-analysis of three studies reporting MIP-1α levels in severe and uncomplicated malaria cases [33,34,40] revealed no significant difference in MIP-1α levels between severe malaria cases (n = 203) and uncomplicated malaria cases (n = 106) (p = 0.5135, random effects model, SMD: −0.4817, 95% CI: −1.9268 to 0.9634, I2: 97.3%, number of studies: three, 309 individuals, Figure 4).